Intet billede af Knud Elnegaard Josefsen

Knud Elnegaard Josefsen


    Publikationer pr. år

    Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

    Personlig profil


    Beta cell physiology, type 1 diabetes, in vitro and vivo models of beta cell function, molecular biology.

    Primære forskningsområder

    Type 1 diabetes, which has a high occurrence in Denmark, and in Scandinavia in general. Although insulin treatment is life-saving for type 1 diabetes patients, it is not a cure. The patients must be treated lifelong with daily injections, and both economical and personal expenses are high. Further, transplantation or immuno-suppressive treatments have no lasting effect or unacceptable side effects.

    We therefore aim for the prevention of the disease and investigate the etiology and pathogenesis of the disease. Through the use of cellular and and animal models, we explore basic mechanisms for beta cell damage and for translation to human disease, we use human data from registers, patient trials and inventories. 

    Aktuel forskning

    Our most recent research involves the role of gluten in the development of the disease. A gluten-free diet is almost curative in rodents, even after disease manifestation, while in humans, it delays the development of the disease. Before such treatment can be applied to humans, the mechanisms responsible for the effect must me clarified. We therefore put much effort into dissecting in vivo changes related to gluten-free diet, including immune system-, intestinal- and pancreatic adaptations.  

    Mulige interessekonflikter



    Dyk ned i forskningsemnerne, hvor Knud Elnegaard Josefsen er aktive. Disse emneetiketter kommer fra denne persons arbejder. Sammen danner de et unikt fingerprint.
    • 1 Lignende profiler


    Seneste eksterne samarbejde på lande-/områdeniveau. Dyk ned i detaljerne ved at klikke på prikkerne eller